Superior Prima Sukses Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Superior Prima Sukses Tbk. trades at Rp140 (market cap 1.25T, 591.3K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 310.75B, 159.2K 24h volume). The key difference: Superior Prima Sukses Tbk. is far larger — about 4× Diagnos Laboratorium Utama Tbk.'s market cap, and Superior Prima Sukses Tbk. is more actively traded (591.3K versus 159.2K). Which is the better fit depends on your goals.
| BLES | DGNS | |
|---|---|---|
Market Cap | 1.25T | 310.75B |
Volume | 591.3K | 159.2K |
Lot | 5.91K | 1.59K |
Turnover | 83.24M | 34.72M |
Average Price | 140.77 | 218.06 |
Value | 83.24M | 34.72M |
Indicative Equilibrium Price | 140 | 220 |
Indicative Equilibrium Volume | 408 | 6 |
Trailing returns across standard periods
Latest headlines on both assets
PT Superior Prima Sukses Tbk (the Company) was established based on Notarial Deed of Sriwati, S.H., M.Hum., No. 8 dated November 3, 2011. The Company started its operations in April 2013. PT Global Base Universal is the ultimate parent entity of the Company.
Read more on BLES →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →